According to research published in “Life Science”, artemisinin – derivative of Sweet wormwood plant (Artemisia annua L., a literal translation from English – the sweet wormwood) used in Chinese medicine – can kill 98% of breast cancer cells in less than 16 hours.
Moreover, it did not affect at all the normal cells in the breast in this experiment.
Artemisinin has been used in the past as a powerful antimalarial agent, but now it has been proven to be effective against cancer.
When the subjects in the study were added iron, which often accumulates in the breast tissue or cells infected especially in cancer, artemisinin selectively attacked the “bad” cells, while “good” cells did not touch.
Iron accumulates in cancer cells with specific receptors that help them sharing cells (called “transferrin” receptors).
Normal cells are likely to have these receptors as well, but cancer cells have them in large quantities, and thus can be targeted by a combination of iron and artemisinin.
There have been lots of experiments that prove that artemisinin can effectively remove the disease in the presence of iron.
This extract has been used for thousands of years in China against malaria.
Malaria parasite cannot live in the presence of Artemisinin because it is full of iron.
Bioengineer Henry Lai and Narendra Singh of the University of Washington, Seattle, is the scientist who first discovered this.
Their research demonstrates that the cancerous cells experiencing apoptosis, or their own destruction.
So far this extract was difficult to obtain at lower prices, but with the increased interest in this plant and the price could be more acceptable.
French drug manufacturer “Sanofi” expects to produce 50-60 tons of Artemisinin each year, hoping to meet the demand of the world market.